Orphenadrine Citrate

CAS 4682-36-4 3 current records 2 historicalSmall Molecule

Who holds supplier records for Orphenadrine Citrate? 3 organisations hold a current record for Orphenadrine Citrate: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 1 of them holds a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (1), Italy (1) and United States (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Orphenadrine Citrate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/orphenadrine-citrate

Reading the evidence

  • 3 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (3)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Orphenadrine Citrate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Orphenadrine Citrate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (1)

Certificates of Suitability on the EDQM register for Orphenadrine Citrate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
R.L. FINE CHEM PRIVATE LIMITED BengaluruIN
CEP 2022-094 - Rev 01
Orphenadrine citrate
Aug 2025—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (2)

Organisations whose Type II DMFs for Orphenadrine Citrate are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • IROPHARM LTD
    Inactive DMF 7837 · filed Dec 1988
  • 3M PHARMACEUTICALS
    Inactive DMF 7108 · filed Aug 1987

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Orphenadrine Citrate is a muscle relaxant used to relieve pain and discomfort caused by strains, sprains, and other muscle injuries. It acts centrally on the brain to produce its muscle relaxant effects.

Chemical identity

IUPAC name
3-carboxy-3,5-dihydroxy-5-oxopentanoate;dimethyl-[2-[(2-methylphenyl)-phenylmethoxy]ethyl]azanium
Canonical SMILES
CC1=CC=CC=C1C(C2=CC=CC=C2)OCC[NH+](C)C.C(C(=O)O)C(CC(=O)[O-])(C(=O)O)O
InChIKey
MMMNTDFSPSQXJP-UHFFFAOYSA-N
Synonyms
Norflex API, banflex, invagesic component orphenadrine citrate, norflex, norgesic component orphenadrine citrate, nsc-757238, orphenadrine dihydrogen citrate

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Muscle Relaxant
Physiologic effect
Centrally-mediated Muscle Relaxation

Therapeutic areas

Musculoskeletal DisordersPain

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Orphenadrine Citrate?

3 organisations hold an active US FDA Type II Drug Master File or a CEP for Orphenadrine Citrate: R L Fine Chem Pvt. Ltd. (India), PROCOS SPA (Italy) and W R GRACE AND CO -CONN (United States). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Orphenadrine Citrate Drug Master Files are active?

R L Fine Chem Pvt. Ltd. (DMF 38456, 33901), PROCOS SPA (DMF 14971) and W R GRACE AND CO -CONN (DMF 5722). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Orphenadrine Citrate records mean?

2 organisations have only inactive Type II DMFs for Orphenadrine Citrate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Orphenadrine Citrate have a European Certificate of Suitability?

Yes. 1 organisation holds a valid CEP for Orphenadrine Citrate on the EDQM register, including R.L. FINE CHEM PRIVATE LIMITED Bengaluru (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Orphenadrine Citrate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Orphenadrine Citrate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.